More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...
For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and sometimes fatal illness stiffens and scars tissue in organs like the lungs, ...
PROVIDENCE, R.I. [Brown University] — To find treatments for connective tissue disorders like fibrosis, scientists need models that can replicate the structure and function of human tissue when it’s ...
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...
Lab-grown skin captures the complexities of real disease to develop more effective treatments for scleroderma and other life-threatening conditions. For the 300,000 Americans living with the immune ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results